pRK5-Myc-TEAD1 Citations (15)

Originally described in: TEAD mediates YAP-dependent gene induction and growth control.
Zhao B, Ye X, Yu J, Li L, Li W, Li S, Yu J, Lin JD, Wang CY, Chinnaiyan AM, Lai ZC, Guan KL Genes Dev. 2008 Jul 15. 22(14):1962-71. PubMed Journal

---

Articles Citing pRK5-Myc-TEAD1

Articles
Neuregulin 1-activated ERBB4 interacts with YAP to induce Hippo pathway target genes and promote cell migration. Haskins JW, Nguyen DX, Stern DF. Sci Signal. 2014 Dec 9;7(355):ra116. doi: 10.1126/scisignal.2005770. PubMed
Optimal myelin elongation relies on YAP activation by axonal growth and inhibition by Crb3/Hippo pathway. Fernando RN, Cotter L, Perrin-Tricaud C, Berthelot J, Bartolami S, Pereira JA, Gonzalez S, Suter U, Tricaud N. Nat Commun. 2016 Jul 20;7:12186. doi: 10.1038/ncomms12186. PubMed
TEAD1/4 exerts oncogenic role and is negatively regulated by miR-4269 in gastric tumorigenesis. Zhou Y, Huang T, Zhang J, Wong CC, Zhang B, Dong Y, Wu F, Tong JHM, Wu WKK, Cheng ASL, Yu J, Kang W, To KF. Oncogene. 2017 Nov 23;36(47):6518-6530. doi: 10.1038/onc.2017.257. Epub 2017 Jul 31. PubMed
Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets. Crook ZR, Sevilla GP, Friend D, Brusniak MY, Bandaranayake AD, Clarke M, Gewe M, Mhyre AJ, Baker D, Strong RK, Bradley P, Olson JM. Nat Commun. 2017 Dec 21;8(1):2244. doi: 10.1038/s41467-017-02098-8. PubMed
Elevated cyclic-AMP represses expression of exchange protein activated by cAMP (EPAC1) by inhibiting YAP-TEAD activity and HDAC-mediated histone deacetylation. Ebrahimighaei R, McNeill MC, Smith SA, Wray JP, Ford KL, Newby AC, Bond M. Biochim Biophys Acta Mol Cell Res. 2019 Oct;1866(10):1634-1649. doi: 10.1016/j.bbamcr.2019.06.013. Epub 2019 Jun 28. PubMed
Transcriptional and posttranscriptional regulation of the SMC-selective blood pressure-associated gene, ARHGAP42. Mangum KD, Freeman EJ, Magin JC, Taylor JM, Mack CP. Am J Physiol Heart Circ Physiol. 2020 Feb 1;318(2):H413-H424. doi: 10.1152/ajpheart.00143.2019. Epub 2019 Dec 30. PubMed
Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway. Kurppa KJ, Liu Y, To C, Zhang T, Fan M, Vajdi A, Knelson EH, Xie Y, Lim K, Cejas P, Portell A, Lizotte PH, Ficarro SB, Li S, Chen T, Haikala HM, Wang H, Bahcall M, Gao Y, Shalhout S, Boettcher S, Shin BH, Thai T, Wilkens MK, Tillgren ML, Mushajiang M, Xu M, Choi J, Bertram AA, Ebert BL, Beroukhim R, Bandopadhayay P, Awad MM, Gokhale PC, Kirschmeier PT, Marto JA, Camargo FD, Haq R, Paweletz CP, Wong KK, Barbie DA, Long HW, Gray NS, Janne PA. Cancer Cell. 2020 Jan 13;37(1):104-122.e12. doi: 10.1016/j.ccell.2019.12.006. PubMed
Lats1/2 Sustain Intestinal Stem Cells and Wnt Activation through TEAD-Dependent and Independent Transcription. Li Q, Sun Y, Jarugumilli GK, Liu S, Dang K, Cotton JL, Xiol J, Chan PY, DeRan M, Ma L, Li R, Zhu LJ, Li JH, Leiter AB, Ip YT, Camargo FD, Luo X, Johnson RL, Wu X, Mao J. Cell Stem Cell. 2020 May 7;26(5):675-692.e8. doi: 10.1016/j.stem.2020.03.002. Epub 2020 Apr 6. PubMed
PPP1CA/YAP/GS/Gln/mTORC1 pathway activates retinal Muller cells during diabetic retinopathy. Guo Y, Cang X, Zhu L, Zhu M, Li A, Wang Z, Zhang Y, Wang X, Song E. Exp Eye Res. 2021 Sep;210:108703. doi: 10.1016/j.exer.2021.108703. Epub 2021 Jul 17. PubMed
Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells. Van Sciver N, Ohashi M, Pauly NP, Bristol JA, Nelson SE, Johannsen EC, Kenney SC. PLoS Pathog. 2021 Aug 2;17(8):e1009783. doi: 10.1371/journal.ppat.1009783. eCollection 2021 Aug. PubMed
TAZ inhibits glucocorticoid receptor and coordinates hepatic glucose homeostasis in normal physiological states. Xu S, Liu Y, Hu R, Wang M, Stohr O, Xiong Y, Chen L, Kang H, Zheng L, Cai S, He L, Wang C, Copps KD, White MF, Miao J. Elife. 2021 Oct 8;10. pii: 57462. doi: 10.7554/eLife.57462. PubMed
Peptide 17 alleviates early hypertensive renal injury by regulating the Hippo/YAP signalling pathway. Xu SB, Xu B, Ma ZH, Huang MQ, Gao ZS, Ni JL. Nephrology (Carlton). 2022 Aug;27(8):712-723. doi: 10.1111/nep.14066. Epub 2022 Jul 5. PubMed
YAP induces an oncogenic transcriptional program through TET1-mediated epigenetic remodeling in liver growth and tumorigenesis. Wu BK, Mei SC, Chen EH, Zheng Y, Pan D. Nat Genet. 2022 Aug;54(8):1202-1213. doi: 10.1038/s41588-022-01119-7. Epub 2022 Jul 14. PubMed
Discovery of a new class of reversible TEA domain transcription factor inhibitors with a novel binding mode. Hu L, Sun Y, Liu S, Erb H, Singh A, Mao J, Luo X, Wu X. Elife. 2022 Nov 18;11:e80210. doi: 10.7554/eLife.80210. PubMed
TM7SF3 controls TEAD1 splicing to prevent MASH-induced liver fibrosis. Isaac R, Bandyopadhyay G, Rohm TV, Kang S, Wang J, Pokhrel N, Sakane S, Zapata R, Libster AM, Vinik Y, Berhan A, Kisseleva T, Borok Z, Zick Y, Telese F, Webster NJG, Olefsky JM. Cell Metab. 2024 May 7;36(5):1030-1043.e7. doi: 10.1016/j.cmet.2024.04.003. Epub 2024 Apr 25. PubMed

If you have published an article using this material, please email us at to have your article added to this page.